Biotechnology
Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Treatment Development
Propanc Biopharma has closed a $4 million public offering to fund development of its novel pancreatic proenzyme therapy targeting cancer stem cells in pancreatic, ovarian, and colorectal cancers.
ABVC BioPharma Receives $450,000 in Q3 Licensing Payments from OncoX Partnership
ABVC BioPharma's receipt of $450,000 in licensing payments from OncoX BioPharma highlights the financial strength of their oncology partnership and positions the company to capitalize on the growing $469 billion cancer therapeutics market.
MyBioSource Launches Validated Anti-CALB2 Antibody for Neuroscience Research
MyBioSource has introduced a validated sheep anti-rat calretinin polyclonal antibody that enables advanced research into calcium signaling, neuroprotection, and neurodegeneration across multiple species.
Soligenix Advances Rare Disease Pipeline with Key Clinical Milestones Expected Through 2026
Soligenix Inc. reports significant progress in its late-stage rare disease treatments, including pivotal Phase 3 cancer trial results due in 2026 and multiple fast-tracked therapies that could transform care for underserved patient populations.
Mitochondrial Therapy Shows Promise in Slowing Aging Effects
A pioneering therapy using placental mitochondria transplantation offers potential to slow or reverse aging by recharging cellular function, representing a significant advancement in treating previously incurable conditions.
Fifty 1 Labs Partners with Stanford Initiative on AI-Driven Pandemic Preparedness
Fifty 1 Labs collaborates with ViRx@Stanford to use artificial intelligence for rapid drug repurposing against emerging viral threats, aiming to strengthen global health security and reduce future pandemic mortality risks.
Calidi Biotherapeutics Secures $6.9 Million in Public Offering to Advance Targeted Cancer Therapies
Calidi Biotherapeutics has closed a $6.9 million public offering, providing crucial funding to advance its clinical-stage targeted therapies for delivering genetic medicines to metastatic cancer sites.
Creative Biolabs Launches Integrated Cell Therapy Platforms to Advance Cancer Immunotherapy
Creative Biolabs has launched fully integrated CAR-T and TIL therapy development platforms, providing researchers and biotech startups with comprehensive services to accelerate the development of next-generation cellular immunotherapies for cancer treatment.
Columbia University Scientists Develop Bacterial Trojan Horse Method to Deliver Anti-Cancer Viruses
Columbia University researchers have engineered bacteria to deliver cancer-killing viruses directly into tumors, bypassing immune system defenses and potentially revolutionizing cancer treatment approaches.
MIT Researchers Develop AI Method to Enhance RNA Nanoparticle Design for Improved Therapeutics
MIT researchers have created an AI-driven approach to optimize RNA nanoparticle design, potentially revolutionizing the delivery of RNA vaccines and treatments while highlighting the growing commercial impact of quantum computing companies like D-Wave.
Jupiter Neurosciences Launches Consumer Longevity Line Nugevia Using Patented JOTROL Technology
Jupiter Neurosciences introduces Nugevia, a direct-to-consumer product line leveraging its clinically proven JOTROL formulation to address mitochondrial health, cognitive function, and skin benefits while generating revenue alongside pharmaceutical development.
Quantum BioPharma Announces Debt Settlement, Equity Grants, and Advisor Departure
Quantum BioPharma has settled outstanding debt through share issuance, granted restricted share units tied to regulatory milestones for its Lucid MS program, and terminated an advisor agreement, reflecting strategic financial and clinical development moves.
Sethera Therapeutics Announces Enzymatic Platform for Advanced Peptide Drug Development
Sethera Therapeutics has published research on an enzymatic platform that creates stable peptide structures, potentially enabling more effective and orally deliverable peptide therapeutics.
Mileutis Wins 2025 AgTech Breakthrough Award for Antibiotic-Free Dairy Therapy
Mileutis has received the 2025 AgTech Breakthrough Award for its antibiotic-free biologic therapy IMILAC, which addresses mastitis in dairy cows while combating antimicrobial resistance and improving milk production sustainability.
Lionheart Health Named Finalist in Octane's 2025 Medical Technology Innovation Awards
Lionheart Health's recognition as a finalist in Octane's High Tech Awards highlights its breakthrough whole body regeneration chamber technology that could extend human healthspan by 20 years through AI-driven organ regeneration.
Creative Biogene Expands Antibody Purification Platform to Support Biotechnology Innovation
Creative Biogene's enhanced antibody purification platform offers scalable, high-yield purification solutions critical for advancing biotech research and development.
Calidi Biotherapeutics Prices $6 Million Public Offering to Advance Clinical-Stage Cancer Therapies
Calidi Biotherapeutics has priced a $6 million public offering to fund development of its Redtail platform, which uses engineered oncolytic viruses to deliver genetic medicines to metastatic cancer sites, addressing high unmet medical needs in oncology.
GeoVax Secures Patent for Multi-Antigen COVID-19 Vaccine Technology
GeoVax Labs has obtained a key U.S. patent for its multi-antigen COVID-19 vaccine technology, strengthening its position in developing next-generation vaccines that could provide broader and more durable protection against evolving variants.
Blood Donor Shortage Worsens as Artificial Substitutes Remain Limited to Emergency Use
A critical shortage of blood donors, particularly those with universal O-negative type, persists due to declining participation and demographic shifts, while artificial blood substitutes like ErythroMer remain years away from replacing human donations for most medical needs.
Biotech Merger Creates OSPRI to Revolutionize Infectious Disease Testing with $30M Backing
The merger of Community Direct DX, Scienetix, and Advanta Genetics R&D into OSPRI creates a vertically-integrated molecular testing platform that reduces PCR testing costs by 20-50% and time by 50-70%, addressing critical accessibility barriers in healthcare diagnostics.
Lantern Pharma Launches AI Tool predictBBB.ai to Revolutionize CNS Drug Development with 94% Accuracy
Lantern Pharma's new AI platform predictBBB.ai addresses the critical challenge of blood-brain barrier permeability in drug development, potentially accelerating treatments for neurological diseases with unprecedented 94% prediction accuracy.
Ascentage Pharma Advances Global Phase III Trial for Lisaftoclax in Higher-Risk MDS Treatment
Ascentage Pharma's GLORA-4 Phase III trial of lisaftoclax, a potential breakthrough for higher-risk myelodysplastic syndrome (MDS), receives FDA and EMA clearance, marking a significant step towards addressing a critical unmet medical need in oncology.
GeoVax to Showcase Mpox Vaccine Progress at Emerging Growth Conference
GeoVax Labs, Inc. will present updates on its GEO-MVA Mpox vaccine development at the Emerging Growth Conference, highlighting potential regulatory acceleration and manufacturing advantages.
Creative Biolabs Advances Antibody Non-GMP Production and Quality Control
Creative Biolabs is addressing the critical need for high-quality, research-grade antibodies and specialized quality control services in the therapeutic antibody development sector.
IndyGeneUS Bio Wins National Recognition for Inclusive Genomics Research
IndyGeneUS Bio, a Baltimore-based life sciences startup, has been awarded first place in the Disabled American Veterans Pitch Competition for its efforts to make genomic research more inclusive for underserved populations.
Fifty 1 Labs and BioSpark AI Pioneer AI-Driven Drug Repurposing with Major Database Achievement
Fifty 1 Labs and BioSpark AI have created a structured database from over 10,000 case reports, marking a significant advancement in AI-driven drug repurposing for complex conditions.
Branded Legacy, Inc. Expands into Biotech and Medical Devices with Acquisition of Bio Legacy Evaluative Group
Branded Legacy, Inc. (OTC: BLEG) has acquired Bio Legacy Evaluative Group, marking its entry into the biotech and medical devices sector with a focus on addressing global health challenges.
Clene Inc. to Share Corporate Update at Emerging Growth Conference
Clene Inc. is set to present a corporate update at the Emerging Growth Conference, highlighting its progress in developing treatments for neurodegenerative diseases.
Lionheart Health Recognized as Top Implantable Stimulator Developer by MedTech Outlook
Lionheart Health, Inc. has been awarded the Top Implantable Stimulator Developer of the Year by MedTech Outlook for its innovative KlothoImplant™ and MicroImplant™ technologies, marking a significant advancement in medical device technology aimed at healthspan and organ regeneration.
Cybin Inc. Advances Mental Health Treatments with Q1 2025 Results and Key Program Updates
Cybin Inc. reports significant progress in its Phase 3 depression program and Phase 2 anxiety study, highlighting advancements in next-generation mental health treatments.